RxSight (RXST) Assets Average (2021 - 2026)
RxSight's (RXST) quarterly Assets Average came in at $328.3 million in Q2 2026, up 5.57% on a YoY basis from $311.0 million in Q2 2025, and up 6.64% quarter-over-quarter from $307.9 million in Q1 2026.
Analysis
RxSight (RXST) Assets Average (2021 - 2026) Analysis & Trends
RxSight (RXST) has reported Assets Average for 6 consecutive years, with $328.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 5.57% year-over-year to $328.3 million; the trailing twelve-month figure through Jun 2026 stood at $328.3 million (up 5.57% YoY), and the FY2025 full-year result was $315.2 million, up 25.8% from the prior year.
- Assets Average advanced to $328.3 million in Q2 2026 per RXST's latest filing, from $307.9 million in the prior quarter.
- Across five years, Assets Average topped out at $328.3 million in Q2 2026 and bottomed at $152.9 million in Q4 2022.
- Historically, Assets Average has averaged $241.6 million across 5 years, with a median of $221.6 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Assets Average declined 22.85% in 2022, then soared 72.7% in 2025.
- Over 5 years, Assets Average stood at $152.9 million in 2022, then grew by 19.14% to $182.2 million in 2023, then soared by 72.62% to $314.5 million in 2024, then retreated by 1.38% to $310.2 million in 2025, then gained by 5.86% to $328.3 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $328.3 million, $307.9 million, and $310.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 10.74 Bn |
| 10 | RxSight | 265.31 Mn | -138.93 Mn | - | 328.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 328.35 Mn |
| Mar 31, 2026 | 307.90 Mn |
| Dec 31, 2025 | 310.17 Mn |
| Sep 30, 2025 | 308.77 Mn |
| Jun 30, 2025 | 311.03 Mn |
| Mar 31, 2025 | 315.80 Mn |
| Dec 31, 2024 | 314.52 Mn |
| Sep 30, 2024 | 307.98 Mn |
| Jun 30, 2024 | 244.33 Mn |
| Mar 31, 2024 | 182.86 Mn |
| Dec 31, 2023 | 182.20 Mn |
| Sep 30, 2023 | 188.56 Mn |
| Jun 30, 2023 | 198.90 Mn |
| Mar 31, 2023 | 176.35 Mn |
| Dec 31, 2022 | 152.94 Mn |
| Sep 30, 2022 | 161.21 Mn |
| Jun 30, 2022 | 171.89 Mn |
| Mar 31, 2022 | 184.89 Mn |
| Dec 31, 2021 | 198.23 Mn |
| Sep 30, 2021 | 149.31 Mn |